Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Aegea Technologies has updated its website, now includes COVID and PCR testing
https://www.aegeabiotech.com
Let's look at how accurate Bozo Berman was;
TAUG consultant John Cesario told a person who takes large positions in stocks that TAUG's new Covid-19 test kit will be approved by the FDA next week
I guess he was right, $2,000,000 was a large position, but he was wrong about my having any FDA knowledge. Furthermore, at the time of that post, nobody was going for FDA clearance as that would have taken a year or more. Companies were trying to get EUA's and all that was required was validation by a CLIA lab, which Biocept was. So no interaction with the FDA was needed.
This is how it starts with consultant Cesario.Put him in charge of a big project look at what happens.
By the way, DECN's Berman could develop that product for $450,000 and it would actually be ready for sale
But he and anyone with 3 brain cells wouldn't give Stella or Lyle a dime because they are stock promoters, always one step away from SEC disaster.
What TAUG says they will fund is one of those Lyle and Stella get rich quick schemes. And TAUG's product will not see the light of day.
And TAUG shareholders will again be Cesarioed.
Very good find. However I never told anyone that a test was going to be FDA approved. So Bozo Berman was full of crap, as usual. In fact, I didn’t invest in Aegea although I was close. A friend did though, $2 mil
I am not sure where Aegea stands with getting FDA clearance, but EUA is guaranteed approval is guaranteed provided they get a partner that can produce 500,000 tests a month.
Sure looks looks this product will see the light of day, unlike Bozo Bermans
Looks like one of those share issuance and convertible notes might have resulted in Seth using $350,000 to strike GOLD. For instance, as far as I know TAUG is the only public entity that has a stake in Aegea (that may have changed in the past 6 months, I am not sure).
If Aegea's test takes off TAUG's investment in Aegea could be worth as much as the TAUG's current market cap!
Aegea seems to have a test that not only is extremely accurate in diagnosing COVID, but can tell the difference between the flu and different variants.
Currently, there are 350,000 DAILY tests alone in the U.S.
Does anyone think Quest or Thermal Fisher will want this test? To get an EUA the FDA now wants a company to be able to be capable of producing 500,000 tests a week. Aegea does not have that capability. They need a big partner.
Also, previously, Aegea told me that this type of test gets a $400 dollar reimbursement as opposed to a $100 reimbursement. I am not sure if that still holds, given the emphasis on home kits, but this test will certainly command more than a normal lab test.
Seth never gets any credit for the good moves he has made, and IMO he has made more good moves than bad trying to put Tauriga in a position to be very successful! This Company started from scratch 2 1/2 years ago.
Aegea could very well become a 1/2 billion dollar company overnight.
Just in the US over 10 million tests are done a month, if Aegea, through a large partner captures just 20% of that business and sells the test for $25 they could generate $50 million dollars a month in revenue.
Aegea also owns multiple switch blocker patents for disease testing. many are very valuable and are just sitting dormant because they have not been discovered. One test, is very highly rated by doctors and hospitals, but unfortunately, Biocept has not been able to commercialize it properly.
The liquid biopsy market is huge! Aegea will get quite a bit of attention in the next few months especially with new variants in the news. That has to draw interest to the other IP's they have. Aegea's CEO is in his 70's so I would think a buyout is a consideration over the next couple years..
https://www.medtechdive.com/news/illumina-inks-8b-grail-buyout-for-liquid-biopsy-market-investors-are-not/585584/
https://www.genomeweb.com/business-news/agilent-technologies-acquire-liquid-biopsy-firm-resolution-bioscience-695m#.YaIlUtDMLZs
Anyway, what is your analysis of this current turn of events?
I don't think there are any convertibles at deep discounts left, and it looks like TAUG stock investments are doing well, so I think they have cash available.
VTGN is up and trading in the low 2's with a Phase 3 readout on the first SAD drug that the FDA has fast tracked and given needed status to. VTGN now has massive institutional ownership and analysts are calling for $9.00 just on that one drug, which isn't there biggest. VTGN went from 0 institutions owning it to some of the biggest, I believe it is over 55% institutionally owned. Including by Franklin Templeton. Funny how Seth's rolodex includes the Head of Global at Franklin.
AXIM.. That stock is up double and could easily double again. The drug works and had a snafu on paperwork submitted to FDA. Keep an eye on that one.
GOEV (W) Looks like things are heating up there finally. They have received nearly $500 million bucks from Arkansas and appear to have over $1 billion in orders for its electric pickup.
Aegea will get interesting because of the latest news, and we are in flu season and new variants.
Serendipity Brands is about to launch a massive advertising campaign with Selena Gomez and I was told that there is discussions with Nesltes about doing 3 drink flavors. They are also launching other products.
While the Serendipity restaurants are not part of the Serendipity Brands they will promote ice cream for sure. NY location, where Presidents and famous stars have gone is remodeled. Miami has opened, and 8 other locations are being built, including inside Disney. The Walburg's have also signed an agreement to put 6 locations up.
GoPuff is a huge partner in Serendipity Brands. They also deliver alcohol in the States where it is allowed. Taug's products could fit in nicely there. I don't think many people at GoPuff are over 35 years old so maybe these products will interest them.
But like I have said repeatedly, the nausea drug trial for chemo patients is the biggest driver for me. I doubt much will happen till the patent is issued, besides the ongoing safety cohort.
If a company like BNOEF can retain 40% of its ownership in its drug through a partnership with MERC I can't see why Tauriga cannot enter into an arrangement like that with a Pharma player. The nausea market is a $7 billion plus annual market and the trial from soup to nuts will be under $80,000,000 That is a bargain as blockbuster drugs average over $1.5 billion dollars on average.
The Aegea announcement is very interesting and a long time coming. This is one of TAUG's investments in a private company, the other being Serendipity. I have no investment in Aegea but do have one in Serendipity.
If Aegea test is validated as the Aegea and Biocept press releases indicate, then Aegea could very well become a very substantial investment for Tauriga.
I believe the original valuation for Aegea was around $10 million dollars. According to what Aegea told me when I was looking at investing in that company a test that can distinguish the difference between the flu and Covid commands a 4 - time reimbursement fee to the lab. A typical reimbursement for a COVID-19 lab test is about $105 per test. According to Aegea this test will get a $400 reimbursement.
Biocept shares one of Aegea's patents for PCR cancer pre screenings. Biocept jumped into Covid testing and went from virtually no sales to $17 mil a quarter.
A test that could distinguish the difference between the flu would be very valuable, take nursing homes and senior living centers as examples. Testing will not go away anytime soon, once PFE and Merc's Covid drugs are approved one would need a positive test to qualify for a prescription. The US has already ordered over $2 billion dollars of PFE's drug.
Go to a CVS and ask for a Delta variant test, they will tell you it cannot be done. If the Aegea test could differentiate between different strains, it could be a billion-dollar company.
Imagine what a company like Quest could do with this test. If Quest did 500,000 tests a month with a reimbursement of just $100 that would be $50 million dollars in revenue a month. At $200 a test it would be $100 million dollars a month. While those seem like pie in the sky projections, currently the US is processing over 350,000 tests a day, or almost 11 million tests a month. That is just in the US. Testing has a global market and Quest has huge contracts with large pharmacies and hospitals.
Emergency Use Authorizations are still being given out for Covid tests, but small companies will not be granted an EUA anymore. However, if a Company is able to manufacture 500,000 tests a week, they would get an EUA combined with the test results Aegea has produced. So they need a big partner or they have to go through the year long process of getting its test FDA cleared.
Just a little food for thought,it sure will be interesting to see how this plays out.
As far as Serendipity Ice Cream, I think things are looking encouraging there as well. Selena Gomez and GoPuff are also now investors like TAUG. GoPuff recently did a capital raise at an $11 Billion dollar valuation.
I hope GoPuff will look at distributing the gums and gummies.
Obviously, the core business is the CBD and other lines, and the huge value driver to shareholders is the Pharma trial for chemotherapy induced nausea, but these are some interesting tidbits.
This is not investment advice but just some interesting facts. I am still very long stock, but as I previously posted the PPS has been a downer the last 6 months.
Taug's stock holdings are interesting as well, VTGN AMIM and GOEVW all are looking good currently, VTGN should have a readout on its Phase 3 social anxiety drug in 2022. That is a multibillion dollar annual market. Most people should remember that VTGN had some dark days, it wasn't long ago that they did not have much cash and had a $40 million market cap. Now it has $100 mil in the bank and a $400 million dollar market cap. If TAUG's drug trial for nausea gets some traction this will be a very intersting story.
I love the products, love them. and I thought CBD was quackery at first. It has helped me, for sure.
Hard to get excited on one day spikes especially because this was oversold and it is unlikely that there were many real sellers at ,03 and .04.
Well, whatever they do with it seems like investors are happy about it. Up over 50% today. Can't wait to see it over a dime.
GLTA
Low OS. Should of bought more TAUG...
I have not seen any private placements or convertibles done at deep discounts lately. I believe the rationale for the increase has to do with the drug trial.
I hope the patent is issued in Q1 and that could open up a world of possibilities because the nausea chemo market is a $7 billion dollar annual spend for drugs that are somewhat effective with side effects.
I suspect that the original patent could have been approved already, but that was for gum delivery only. As I understand it, the patent application was changed to include other orals. Obviously, chewing gum delivery also has an additional process patent.
After the $7.2 Billion dollar buyout of the only FDA approved drug this year you can bet Big Pharma is exploring ways to monetize CBD, and not just CBD but mushrooms as well.
Nestles had no CBD products when Taurigum was launched. Nestles approved its largest Hagen das distributer to distribute the gum 2 years ago. Unfortunately, right after that approval, the Governor of New York banned CBD sales. That ban has now been lifted.
Nestles, as well as other food companies, sell CBD products. Garden Of Life is actually in the safety trial Cohort with Tauriga.
I am sure you are aware of that as I have posted that several times months ago along with their PowerPoint.
This is currently a $12 million dollar market cap. Not only does that seem stupidly low based on their retail products, but the potential of a positive drug trial is huge. Granted, drug trails are risky and not guaranteed by any means, but this trial is not attempting to cure a disease, but it is to mitigate he nausea effects of Chemotherapy treatments.
There is also quite a potential for an over the counter nausea chewing gum.
The stock price has certainly been disappointing over the last 6 months for sure. But with chains like Pilot picking up the gum the retail looks promising. There will be a day when the CVS's Walmart's Amazon's Target's of the world allow CBD sales, and that could also be a huge win.
No idea. But historically the vast majority of their issuances are note conversions and private placements at deep discounts to the market price.
What are they planning on doing with the additional shares? Never liked the current name but more share dilution is a concern.
"At the Special Meeting, Tauriga’s stockholders approved an amendment to our Articles of Incorporation to (collectively, “Proposal 1”) to: (i) allow for consideration of the change of the name of our Company to Sublingual Technologies Inc.; (ii) allow action by our Board of Directors to affect a change in the name of our Company without further shareholder approval; and (iii) to increase the total number of authorized shares of common stock, par value $.00001 per share (“Common Stock”) from 400,000,000 to 750,000,000 shares."
Yes, tax selling and waiting for meaningful updates on the patent and drug trial.
Company doing everything right the price is a total joke wtf?
Thanks for the detailed response. I sort of anticipated Q1 2022 but that was just a guess.
On the surface it certainly seems like the Company has very competent patent attorneys, and having experience with other CBD compounds is certainly a plus.
Not going to go back to look for links, but I think some of the Berman suck ups wrote nonsense like there was no patent application.
In any event, assuming the patent is issued as applied for, next will be determining if the formulation has value in a clinical setting. Given the number of CBD trials now coupled with the Jazz Pharmaceutical purchase it will be interesting to see what valuation this will become.
USPTO will not approve any trademark related to cannabis or CBD/hemp which is why they are dead. However, filing these puts a marker down for the time in the future when USPTO will allow these trademarks.
The patent is following the normal pathway at USPTO.
USPTO transaction history from USPTO portal:
Transaction History
Date Transaction Description
09-24-2021 Email Notification
09-23-2021 Application ready for PDX access by participating foreign offices
09-23-2021 PG-Pub Issue Notification
08-22-2021 Case Docketed to Examiner in GAU
The key item is the patent application has been assigned (docketed) to an Examiner. It usually takes several months for an Examiner to review and respond. First response is always a rejection notice. Then an iterative process working around any "prior art" the Examiner references in a rejection. Patent issuance can takes months or years depending on the complexity of the review/response cycle with the Examiner.
The claims are very well presented as both a composition and method. The Examiner will probably require a split of the composition and the method which is not an issue and only strengthens the IP since the potential is to be issued two patents. IP attorneys write the claims this way knowing it will be split by the Examiner (Patent 101 by attorneys).
And it was progress and it was news 6 weeks ago when it actually happened.
"So, if 18 months is normal how long do you think it will be until the patent is issued?"
I didn't say "normal. I said "routine", as in "by law".
No idea how long it will take until (or if) a patent is issued.
Lets wait and see what the inspector has to say. Remember, we're talking about a CEO who couldn't even secure a trademark and that should have been a cakewalk.
88388347 TAURIG-GUMMI TSDR DEAD
88388327 TAURI-GUMMIES TSDR DEAD
88226543 TAURI-GUM TSDR DEAD
87238428 COLLUM AUXILIUM COLLUMAUXIL LLC TSDR DEAD
87266443 ROLLEAF TSDR DEAD
87266438 ROLLEAF! TSDR DEAD
But there are 2 NEW Trademark applications on file...for Tauri-sun and Tauri-_____ (something else)....that haven't been seen by an inspector yet (so they aren't DEAD yet). And they have their own little tricks to them, at least the Tauri-sun version does and I haven't looked at the other but expect it has the same flaws:
An application was filed. 15 minutes later a second Tauri-sun Application was filed which included the required owner phone number (2024149249) that had been left out of the original. They had to put a number on the application but the one they used isn't Tauriga's (It's SUPPOSED to be)! Whose is it?
The Application also requires an email address for the trademark owner. The form was filed with "XXXX" in the space provided for that address. Tauriga doesn't have an email address? Swifty the lawyer knew that wouldn't fly so he included the following footnote:
"Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS)."
Does he really think that that solves the problem?
The Patent application process is orders of magnitude more complicated than the Trademark process and Tauriga has yet to show that it can even get that incredibly simple task done. I see two more DEAD's on the TAUG Trademark list in Tauriga's future.
"how long do you think it will be until the patent is issued?"
If their Trademark pursuit is any gauge there's a good chance that a patent will never be issued, but in the case of a patent it can take a long, long time to find that out. I think my guess is solid but as long as the money keeps flowing a patent attorney can drag things out for years. Lets see what the Inspector has to say (when he stops laughing).
ps. "I remember some Bozos thinking no provisional patent was applied for, and even that an actual patent application was never filed."
Memories can fail us (I know mine does sometimes). Do you have links to the posts where those assertions were made?
I would call that progress. I remember some Bozos thinking no provisional patent was applied for, and even that an actual patent application was never filed.
So, if 18 months is normal how long do you think it will be until the patent is issued?
I see that it covers multiple oral delivery methods. Do you think this patent will cover pharma and over the counter applications? That would be sweet.
WooHoooo!!!
Tauriga Sciences receives Notice of Publication from U.S. patents office
Announced as if its news...it's not. They received the notice over a month ago (September 23rd), 18 months from the filing date. It's very routine and hardly newsworthy.
This is not worth knowing:
"The USPTO provided the Company with the following Publication #: US-2021-0290564-A1"
This IS worth knowing but I guess Tauriga either didn't know how to provide it or chose not to:
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PG01&s1=%2217%2F204,106%22&OS=%2217/204,106%22&RS=%2217/204,106%22
I don't think the Nestle connection is well known. Just because there is a connection doesn't guarantee anything. But hopefully the patent will be granted by year end
Thanks for the information Johnny I've been patiently watching this for a long time don't understand why the Nestle connection didn't move the PPS it seems to move from .03-.04 to .10 need have something bigger to move this to the next level GLTA !!!
Patience I think. I think the retail side will start growing now but the big payoff is the pharma potential.
Safety trial has already started enrollment and it is very interesting Nestle Garden of Life product is also in this trial. Nestle had zero CBD products until taug had to vette gum through the NY distributor that was originally going to put the gum in NY stores
Patent application for Nausea includes all oral deliveries I believe. The nausea market is estimated at $7 billion annually. Over the counter product for pregnancy is interesting as well.
To soon to tell but I think this trial will be closely watched by pharma
The Special Meeting will be held for the following purposes:
1. Approve an amendment to our Articles of Incorporation to (collectively, “Proposal 1”):
(i) change the name of our Company to Sublingual Technologies Inc. to align with our current core business;
(ii) to allow, including under the Florida Business Corporations Act Section 607.1002, action by our Board of Directors to affect a future change in the name of our Company without shareholder approval; and
(iii) to increase the total number of authorized shares of common stock, par value $.00001 per share (“Common Stock”) from 400,000,000 to 750,000,000 shares;
Positive News came out and nothing to PPS what's it going to take to move this above .10 ??
Good stuff thanks for the info let's see how PPS reacts
So quite is anything happening ??? Is management still on vacation ?
Good question, was retail value used as opposed to wholesale cost. 10mg gum was discounted out to make way for 25mg.
Hope by year-end the safety trial is completed, Nestles Garden of Life is also in the trial.
Wonder when the patent on Pharma / OTC product will be issued. It would be nice if it were issued in 2021
I thought press release headlines had to be true.
This one sure isn't:
Tauriga Sciences, Inc. Initiates Clinical Trial to Examine the Effects of Cannabidiol Doses on Pregnant Women with Diagnosis of Hyperemesis Gravidarum
TAUG hasn't initiated a clinical trial. They say so themselves:
"The Company is currently in the process of finalizing the study protocol, to be submitted, reviewed, and approved by a central Institutional Review Board (“IRB”)."
You can't initiate a trial without first finalizing the protocol for the trial.
They're just getting ready to get ready. When a clinical trial is actually initiated it should appear here not later than 21 calendar days after enrolling the first human subject:
https://clinicaltrials.gov/ct2/results?cond=&term=tauriga&cntry=&state=&city=&dist=
When?
Where?
How?
This is almost certainly bullshit:
"The amount listed for Inventory was transcribed incorrectly from our records and was not noticed prior to the publication of this report. The sum of the Current assets was different than the total presented. The total of inventory on hand of $201,372 instead of the previously reported $647,013."
For some reason (did anyone see an explanation?) the Company fronted the money for more than $400K of inventory and instead of admitting that they treated it all as if it was "Inventory on hand". Someone caught on and they were forced to reclassify it in an Amended 10-K to what they called "Prepaid Inventory". The bullshit part is the explanation:
"The amount listed for Inventory was transcribed incorrectly from our records and was not noticed prior to the publication of this report."
1. transcribed incorrectly from our records .
2. not noticed prior to the publication of this report.
A $445,000 mistake. Just a copy and paste error? Wasn't noticed?
Come on people.
Revenues for the three months ended June 30, 2021 $33,367
Revenues for the three months ended June 30, 2020 $64,804
23 press releases during a quarter in which they did $33,367 in Sales. They came pretty close to cutting the prior year's sales in half.
https://tauriga.com/press-releases/
Laughable.
Gonna operate a table. Woohooooo!!!
"The Company was materially affected by COVID-19 related production delays, between the months of May-July 2021."
They left out the "Oh, by the way".
If the Company was truly materially affected as they say, then they were obligated to file an 8-K as soon as they were aware of it.
TAUG News: Amended Annual Report (10-k/a)
The Scrivener done it? LOL.
Shaw and the Directors signed off on the numbers and the Auditors rendered their opinion on them....but the Scrivener gets the blame because they were wrong.
Okay, deceptions.
What lies? And as far as Amazon I think the gum has finally been approved for sale by Amazon, making it the first CBD gum, and actually the first oral CBD product.
I say I think not because Amazon hasn’t approved it, they have, but Amazon has approved products only to change course.
The reason why the gums were not listed on Amazon is because TAUG didn’t have the 25mg gum in stock. That is the flagship.
And retail sales eventually could be substantial, but if one is looking for big stock appreciation that will only come from the 2 nausea products, one a pharma item and one an over the counter.
Hopefully the patents are approved shortly
If "Retail sales are just a bonus" they shouldn't have to lie about them.
Retail sales are just a bonus. The play here is the pharma and OTC nausea products.
Pretty simple!
Sounds to me as if these jokers are trying to pull another fast one. Here's what I think is happening:
"Tauriga Sciences Inc. Generates Record Daily E-Commerce Revenue for Sunday, July 25, 2021"
Even a little kid would be asking "Daddy, didn't they mean to say ON Sunday, July 25 instead of FOR Sunday, July 25?".
They tried to bury the explanation for their odd choice of language.
"This E-Commerce “Daily” sales record was driven by the recent arrivals of new product inventory".
Two things to note:
1. The quotation marks around "Daily" are in the original as provided by the Company. Why are they there? Don't we all know what "daily" means? What are they up to?
2. Were the orders that made up the record revenue for July 25th received and filled on July 25th? Revenue is to be recognized on the date of shipment according to generally accepted accounting principles. So what are they telling us here?
"This E-Commerce “Daily” sales record was driven by the recent arrivals of new product inventory...".
Here's what I think happened:
They took orders for a group of items (see the list in the PR) for which they didn't have stock. The stock eventually came in and on July 25th they shipped those pre-existing orders. That was their justification for saying they had record revenue of $13,000 on that day, but they didn't receive $13,000 in orders on that day.
Using "for" instead of "on" lets them pull that bullshit off.
Tell me I'm wrong, Tauriga. I'll bet I'm not.
Yup need some big news. Watching for now.
Wow this stock is dead. Shocker. LMAO!!!!
Followers
|
350
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
54032
|
Created
|
07/26/09
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |